Insmed INSM
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Insmed (INSM) Business Model and Operations Summary
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Key Insights
Insmed (INSM) Core Market Data and Business Metrics
Latest Closing Price
$68.57Market Cap
$12.32 BillionAverage Daily Trade Volume
1,904,941 SharesTotal Outstanding Shares
181.82 Million SharesCEO
Mr. William H. Lewis J.D., M.B.A.Total Employees
1,271Dividend
No dividendIPO Date
June 1, 2000SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
700 Us Highway 202/206, Bridgewater, NJ, 08807
Historical Stock Splits
| Execution Date | Split Amount |
|---|
Short Interest
Short Interest
This information is bi-monthly aggregated short interest data reported to the Financial Industry Regulatory Authority (FINRA) by broker-dealers.
Short Interest: The total number of shares that have been sold short but have not yet been covered or closed out.
Settlement Date: The date on which the short interest data is considered settled, typically based on exchange reporting schedules.
Bi-Weekly Change (%): The percentage change in short interest from the previous bi-weekly period.
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Short Interest | Settlement Date | Bi-Weekly Change (%) |
|---|---|---|
| 14.50 Million Shares | 3/31/2025 | +0.25% |
| 14.47 Million Shares | 3/14/2025 | -1.01% |
| 14.62 Million Shares | 2/28/2025 | +1.04% |
| 14.46 Million Shares | 2/14/2025 | -0.51% |
| 14.54 Million Shares | 1/31/2025 | -3.65% |
| 15.09 Million Shares | 1/15/2025 | -2.28% |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||